Mark Leschly Rho Managing Partner. Mark has spent over thirteen years in the venture capital and private equity business. Paul joined Rho in 1999, before Rho Mark was into health and spent five years at Healthcare Ventures where he was a general partner.
Mark Leschly previously had several years of management consulting experience at McKinsey & Company. Mark received an MBA from Stanford Graduate School of Business. His current and former board involvement includes:
Anacor,
Archemix,
BroadLogic,
Gloucester,
Inotek, Memory Pharmaceuticals, MPV, NitroMed, Orametrix, Orqis, Ripe Digital Entertainment, Senomyx, SiTV, Slacker, Tercica, TolerRx, Vanda Pharmaceuticals, Verenium (formerly Diversa), and Vicuron.
Mark has lots on his hands, he is Managing Partner of Rho Capital Partners and Rho Ventures and serves on the investment committee of Rho Fund Investors.
Tags: Leschly, Managing, Mark, partner, rho